Prognostic Markers and Tumour Growth Kinetics in Melanoma Patients Progressing on Vemurafenib
Melanoma Research - United States
doi 10.1097/cmr.0000000000000218
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)